GPT Healthcare Ltd
GPT Healthcare Q4 FY25 earnings call: Revenue & Margins
Q4 FY25 earnings call: what management guided on revenue, margins and order book.
The short version
The company expects a 15% year-on-year (Y-o-Y) growth driven by new hospitals and introduction of newer specialties in existing hospitals. GPT Healthcare expects a 15% year-on-year growth driven by new hospitals and introduction of newer specialties across existing hospitals.
From GPT Healthcare Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- The company expects a 15% year-on-year (Y-o-Y) growth driven by new hospitals and introduction of newer specialties in existing hospitals.
- Growth has been historically over 15% CAGR, though FY '25 saw largely flat volume growth due to external factors.
- New hospital in Raipur expected to stabilize occupancies around 20% in the first year, breakeven at 35% occupancy within 24 months.
- Jamshedpur hospital planned with 150 beds, expected commissioning by end of Q3 FY '27, contributing to future growth.
- Focus on increasing Average Revenue Per Occupied Bed (ARPOB) by 8-12% annually across hospitals through specialty services and short-stay surgeries.
2 more points from GPT Healthcare Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what GPT Healthcare Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Commissioned a 158-bed facility at Pachpedi Naka in Raipur on May 2, 2025, under an asset-light rental model, marking significant capital investment.
- Signed an MoU for a new 150-bed hospital in Jamshedpur with an estimated investment of approximately INR 65 crores; expected commissioning by end of Q3 FY '27.
- Plans to scale up to a 1,000-bed hospital chain over the next 2 to 3 years through such expansions.
- Raipur hospital project cost was approximately INR 55 crores.
2 more points from GPT Healthcare Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what GPT Healthcare Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from GPT Healthcare Ltd's call on order book
Pro opens every point from 15K+ earnings calls
GPT Healthcare Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹126 Cr, net profit ₹15 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What GPT Healthcare Ltd's management said in earlier quarters
Others in Healthcare Services this season
- 3B Blackbio (Q4 FY25)
UK subsidiary (TRUPCR Europe Limited) revenue FY 2024-25: GBP 1,287,580, a 94% increase over FY 2023-24 GBP 664,059. Key concall takeaways from 3B Blackbio DX…
- Apollo Hospitals Enterprise Ltd (Q4 FY25)
. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q4 FY25 earnings call — and how it ranks against sector peers.
- Shalby (Q4 FY25)
Implant business is in high-growth mode: 4x growth in Indonesia, 35-40% growth in U.S., and 2.5x growth in India reported last year. Key concall takeaways from…
- Suraksha Diagnostic Ltd (Q4 FY25)
Volume of tests conducted has been growing at around 10% year-on-year between FY '24 and FY '25. Key concall takeaways from Suraksha Diagnostic Ltd's Q4 FY25…
Arthneeti Pro · Annual
GPT Healthcare Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were GPT Healthcare Ltd Q4 FY25 results?
The company expects a 15% year-on-year (Y-o-Y) growth driven by new hospitals and introduction of newer specialties in existing hospitals. GPT Healthcare expects a 15% year-on-year growth driven by new hospitals and introduction of newer specialties across existing hospitals.
What is GPT Healthcare Ltd share price analysis?
GPT Healthcare Ltd currently shows a neutral. The stock trades at a P/E of 27.1 with a market cap of ₹1,281 Cr. Investors should review the full earnings analysis for detailed insights.
Is GPT Healthcare Ltd planning capital expenditure?
Commissioned a 158-bed facility at Pachpedi Naka in Raipur on May 2, 2025, under an asset-light rental model, marking significant capital investment.
Keep GPT Healthcare Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.